How Does Epidiolex Work?

How Does Epidiolex Work? And How Does It Differ From Hemp Oil?

It’s official, the FDA has approved the first cannabis derived prescription drug. Based on years of research, Epidiolex has proven benefits in treating two rare forms of epilepsy (Dravet Syndrome and Lennox-Gastaut Syndrome). So what does that mean for everyone else? Epidiolex contains CBD isolate, which is also found in a number of nutraceutical hemp products. Up until now, all forms of CBD (with exception to Farm Bill Compliant hemp derived CBD) have been classified as a Schedule I drug. Although we can’t be certain how the FDA’s approval will affect the cannabis industry, we can offer our thoughts. So, let’s look at the facts.

CBD Isolate vs Full Spectrum Hemp Oil

CBD isolate (the cannabis derived ingredient in Epidiolex) is a refined version of full spectrum hemp oil containing only pure CBD. While proven to show health benefits, CBD isolate is just one of numerous cannabinoids that our body is made to absorb, along with numerous flavonoids and terpenoids that are stripped away in the refining process.

Hemp extract contains a variety of cannabinoids, such as CBD, that target specific cannabinoid receptors throughout the body. When using full spectrum hemp products, multiple cannabinoids, terpenoids and receptors work together to increase the efficacy of cannabis based products. This process is often referred to as the “entourage effect”. Although CBD isolate found in Epidiolex is proven to show health benefits for two specific forms of epilepsy, some will still prefer (and be limited to) wholistic full spectrum hemp oil.

How the FDA’s Approval helps the CBD Industry:

  • CBD being reclassified to Schedule II or III (within 90 days)
  • Making the cannabinoid industry as a whole more credible
  • Higher quality standards and oversight
  • Proves that CBD has medicinal value
  • Opens the door to more research
Green Lotus FDA Logo


Regardless of being FDA approved, the question “How much will it cost?” is still a top concern. A year’s prescription of Epidiolex is estimated to cost upwards of $32,000. Even after insurance, it’s likely that Epidiolex will have a cost comparable to over-the-counter alternatives. Before any of that can happen, the DEA still has to reclassify CBD. Currently marijuana and CBD are considered a Schedule I drug. The FDA granted Epidiolex Fast-Track designation for use with Dravet syndrome, and Orphan Drug designation for both Dravet syndrome and Lennox-Gastaut syndrome. With the FDA’s approval of epidiolex, the DEA now has 90 days (as of June 25, 2018) to reclassify CBD as a Schedule II or Schedule III drug. “We don’t have a choice on that,” DEA public affairs officer Barbara Carreno told Business Insider.


With exception to “off label prescribing”, this new drug will be limited to individuals with either of the two previously mentioned types of epilepsy. This means that for those of you looking to use CBD as a remedy for anxiety, appetite, pain, immunity and memory (among others), you’ll likely have to stick with alternative over-the-counter supplements. And while we’re here, it’s worth mentioning the potential negative side effects of Epidiolex, “sleepiness, sedation and lethargy, elevated liver enzymes, decreased appetite, diarrhea, rash, fatigue, malaise and weakness, insomnia, sleep disorder and poor quality sleep, and infections.”

Not All Hemp Companies are Equal

The cannabis industry has grown to where it is today because of early pioneers who were able to look passed common misconceptions and saw potential in the complex cannabis plant. Now with tensions lightening up, larger retailers offering natural supplements will likely take on CBD brands as this industry gains more validity. Hemp companies that set higher standards will be positioned for long-term success as the industry continues to grow.

What Cannabinoid Companies Should Focus On:

  • GMP manufacturing processes
  • Increased self-regulation 3rd party testing
  • Being open and transparent
  • Customer service Education

Final Thoughts

Overall, the FDA’s approval of Epidiolex is likely a good move for the cannabis industry as a whole. It helps the industry become more credible, sets higher quality expectations, proves that CBD has medicinal value, and will likely encourage further research on cannabinoids and their potential health benefits. As we always say here at Green Lotus Hemp, #LetsGrowTogether.

Curious for More?

Learn about the therapeutic benefits of full spectrum hemp oil, hemp news, tips, and reviews of the latest cannabinoid research.

One thought on “How Does Epidiolex Work? And How Does It Differ From Hemp Oil?

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses cookies to offer you a better browsing experience. By browsing this website, you agree to our use of cookies.